AMRX
Price
$8.23
Change
-$0.15 (-1.79%)
Updated
Apr 1 closing price
Capitalization
1.87B
30 days until earnings call
ORGO
Price
$4.28
Change
-$0.04 (-0.93%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
374.78M
35 days until earnings call
Ad is loading...

AMRX vs ORGO

Header iconAMRX vs ORGO Comparison
Open Charts AMRX vs ORGOBanner chart's image
Amneal Pharmaceuticals
Price$8.23
Change-$0.15 (-1.79%)
Volume$2M
Capitalization1.87B
Organogenesis Holdings
Price$4.28
Change-$0.04 (-0.93%)
Volume$36.04K
Capitalization374.78M
AMRX vs ORGO Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. ORGO commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and ORGO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (AMRX: $8.38 vs. ORGO: $4.32)
Brand notoriety: AMRX and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 160% vs. ORGO: 84%
Market capitalization -- AMRX: $1.87B vs. ORGO: $374.78M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, AMRX is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while ORGO’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 5 bearish.
  • ORGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ORGO is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -5.74% price change this week, while ORGO (@Pharmaceuticals: Other) price change was -20.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.28%. For the same industry, the average monthly price growth was -2.37%, and the average quarterly price growth was +50.06%.

Reported Earning Dates

AMRX is expected to report earnings on May 02, 2025.

ORGO is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than ORGO($375M). AMRX has higher P/E ratio than ORGO: AMRX (90.00) vs ORGO (70.25). ORGO YTD gains are higher at: 35.000 vs. AMRX (5.808). AMRX has higher annual earnings (EBITDA): 400M vs. ORGO (36M). ORGO has more cash in the bank: 104M vs. AMRX (91.5M). ORGO has less debt than AMRX: ORGO (119M) vs AMRX (2.75B). AMRX has higher revenues than ORGO: AMRX (2.39B) vs ORGO (433M).
AMRXORGOAMRX / ORGO
Capitalization1.87B375M499%
EBITDA400M36M1,111%
Gain YTD5.80835.00017%
P/E Ratio90.0070.25128%
Revenue2.39B433M553%
Total Cash91.5M104M88%
Total Debt2.75B119M2,312%
FUNDAMENTALS RATINGS
AMRX vs ORGO: Fundamental Ratings
AMRX
ORGO
OUTLOOK RATING
1..100
8088
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
4395
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
4736
P/E GROWTH RATING
1..100
227
SEASONALITY SCORE
1..100
4n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (71) in the Financial Conglomerates industry is in the same range as AMRX (95) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for ORGO (95) in the Financial Conglomerates industry. This means that AMRX’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's SMR Rating (91) in the Financial Conglomerates industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

ORGO's Price Growth Rating (36) in the Financial Conglomerates industry is in the same range as AMRX (47) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

ORGO's P/E Growth Rating (7) in the Financial Conglomerates industry is in the same range as AMRX (22) in the Pharmaceuticals Major industry. This means that ORGO’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXORGO
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJSTX14.28N/A
N/A
VY® JPMorgan Small Cap Core Equity S2
PGOAX19.22N/A
N/A
PGIM Jennison Small Company A
AGCLX16.95N/A
N/A
American Century Global Small Cap A
NBHEX13.94N/A
N/A
Neuberger Berman Equity Income E
DFIEX16.48-0.16
-0.96%
DFA International Core Equity I

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with PRGO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-4.00%
PRGO - ORGO
46%
Loosely correlated
-0.07%
ANIP - ORGO
43%
Loosely correlated
-0.98%
AMRX - ORGO
30%
Poorly correlated
+1.21%
ACET - ORGO
29%
Poorly correlated
-9.06%
AMPH - ORGO
27%
Poorly correlated
+1.97%
More